Literature DB >> 11988814

Local anaesthetic endonasal endoscopic laser dacryocystorhinostomy: analysis of patients' acceptability and various factors affecting the success of this procedure.

A Tripathi1, T H J Lesser, N P O'Donnell, S White.   

Abstract

BACKGROUND AND OBJECTIVES: Endonasal endoscopic laser dacryocystorhinostomy is now a well established, effective approach to relieve nasolacrimal duct obstruction. Whereas attempts have been made to comment on the efficacy of the procedure, no study has been conducted to evaluate the acceptability of this procedure by those at the receiving end, ie, the patients. An attempt has been made in the present study to critically evaluate the procedure from the point of view of patients' acceptability and also to evaluate certain factors which may influence the success rate of this procedure. PATIENTS AND METHODS: Forty-six eyes from 40 patients underwent endonasal endoscopic laser dacryocystorhinostomy, performed by the same surgeon, over a period of 15 months. Various aspects of the procedure were evaluated by patients by filling out a simple questionnaire (Figure 1). In addition to recording patients' views, success of the procedure was confirmed by performing a postoperative sac washout in the clinic. Patients were also subdivided according to their age, duration of symptoms and history of previous surgical intervention. The data were statistically analysed using chi-square tests with the Yates correction.
RESULTS: The percentage of patients who declared themselves completely cured was 65.22%. A partial resolution was felt by 23.91% of patients and no improvement was reported by 10.87% of patients. Forty-two out of the 46 eyes (91.3%) achieved anatomical success by the procedure, as shown by a postoperative sac washout performed in the clinic. Some of them, however, did not have complete resolution of their symptoms perhaps due to an additional factor of lacrimal pump dysfunction in these patients. During the procedure 60.86% of eyes felt no discomfort at all whereas 39.14% of eyes felt some discomfort at some point of time during the procedure (Table 1). When directly asked 86.12% of patients recommended the procedure (implying that the procedure had some good effect on their quality of life), 8.33% of patients did not recommend it and 5.55% of patients made no comments. Various factors affecting the success of this procedure were analysed (Table 2) and it was found that eyes which had no previous surgical intervention showed a complete cure rate which was significantly higher than that seen in eyes which had some sort of previous intervention (P = 0.0003); eyes with a short (<6 mths) duration of symptoms showed significantly higher success rates (P = 0.0098) in comparison to that shown by eyes with longer (>6 mths) duration of symptoms; and younger patients (<50 yrs) had a complete resolution rate much higher than patients over 50 yrs of age (P = 0.0309).
CONCLUSION: The present study clearly shows that endonasal endoscopic laser DCR is an effective procedure, well tolerated and recommended by the patients. Discomfort during the procedure is not a major problem. Younger patients, with no previous surgical intervention and with short duration of symptoms are likely to be benefited the most. Though success rates are higher with external DCR, endonasal endoscopic laser DCR offers certain advantages over the external approach while keeping the option of external DCR open, if needed at a later date.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11988814     DOI: 10.1038/sj.eye.6700083

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  9 in total

1.  Long-term results of endonasal dacryocystorhinostomy.

Authors:  Johannes Zenk; Alexander D Karatzanis; George Psychogios; Katrin Franzke; Michael Koch; Joachim Hornung; George A Velegrakis; Heinrich Iro
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-05-26       Impact factor: 2.503

2.  Outcomes of endoscopic endonasal dacryocystorhinostomy for intractable lacrimal dacryostenosis and associated factors.

Authors:  Tohru Tanigawa; Hirokazu Sasaki; Hiroshi Nonoyama; Yuichiro Horibe; Kunihiro Nishimura; Tetsuro Hoshino; Tetsuya Ogawa; Kenta Murotani; Hiromi Ueda; Masahiro Kaneda
Journal:  Int J Ophthalmol       Date:  2016-10-18       Impact factor: 1.779

3.  Transcanalicular diode laser-assisted dacryocystorhinostomy.

Authors:  Brigita Drnovsek-Olup; Matej Beltram
Journal:  Indian J Ophthalmol       Date:  2010 May-Jun       Impact factor: 1.848

4.  Symptom assessment in patients with functional and primary acquired nasolacrimal duct obstruction before and after successful dacryocystorhinostomy surgery: a prospective study.

Authors:  L M Cheung; I C Francis; F Stapleton; G Wilcsek
Journal:  Br J Ophthalmol       Date:  2007-06-21       Impact factor: 4.638

5.  Patient satisfaction following endoscopic endonasal dacryocystorhinostomy: a quality of life study.

Authors:  G Jutley; R Karim; N Joharatnam; S Latif; T Lynch; J M Olver
Journal:  Eye (Lond)       Date:  2013-07-12       Impact factor: 3.775

6.  Assessment and management of proximal and incomplete symptomatic obstruction of the lacrimal drainage system.

Authors:  Mohsen Bahmani Kashkouli; Farzad Pakdel; Victoria Kiavash
Journal:  Middle East Afr J Ophthalmol       Date:  2012-01

7.  Endoscopic anatomy of the lacrimal sac for dacryocystorhinostomy. A cadaveric study.

Authors:  Ameen Alherabi; Osama Marglani; Islam Herzallah; Hassan Shaibah; Tariq Alaidarous; Haddad Alkaff; Mian Farooq; Ashjan Bamahfouz; Talal Al-Khatib; Hani Marzouki
Journal:  Saudi Med J       Date:  2017-03       Impact factor: 1.484

8.  Clinical outcome of endonasal KTP laser assisted dacryocystorhinostomy.

Authors:  Thomas Ressiniotis; Gerasimos M Voros; Vasilios T Kostakis; Sean Carrie; Christopher Neoh
Journal:  BMC Ophthalmol       Date:  2005-03-03       Impact factor: 2.209

9.  Surgical outcomes of endoscopic dacryocystorhinostomy: analysis of age effect.

Authors:  Jae Yun Sung; Yeon Hee Lee; Kyoung Nam Kim; Tae Seen Kang; Sung Bok Lee
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.